Prometheus launches Crohn’s Prognostic test
Prometheus launches Crohn’s Prognostic test
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn’s Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
Read more on News-Medical-Net
Categories: Breast Cancer Doctors Tags: Crohn's, Launches, Prognostic, Prometheus, test